Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr;111(4):715-717.
doi: 10.1002/cpt.2547.

Therapeutic Innovations in Neuroscience: What's New on the Horizon?

Iris K Minichmayr  1 , Paulien Ravenstijn  2 , Piet H van der Graaf  3   4 , Spiros Vamvakas  5
Affiliations
Editorial

Therapeutic Innovations in Neuroscience: What's New on the Horizon?

Iris K Minichmayr et al. Clin Pharmacol Ther. 2022 Apr.
No abstract available

PubMed Disclaimer

References

    1. Abuasal, B. et al. Clinical pharmacology in drug development for rare diseases in neurology: contributions and opportunities. Clin. Pharmacol. Ther. 111, 786-798 (2022).
    1. Stephenson, D., Ollivier, C., Brinton, R. & Barrett, J. Can innovative trial designs in orphan diseases drive advancement of treatments for common neurological diseases? Clin. Pharmacol. Ther. 111, 799-806 (2022).
    1. van Eijk, R.P.A., Roes, K.C.B., de Greef-van der sandt, I., van den Berg, L.H. & Lu, Y. Functional loss and mortality in randomized clinical trials for amyotrophic lateral sclerosis: to combine, or not to combine - that is the estimand. Clin. Pharmacol. Ther. 111, 817-825 (2022).
    1. Romer, K., Marquardt, O. & Ungerleider, S. Family driven development of treatments for rare pediatric neurological diseases. Clin. Pharmacol. Ther. 111, 736-739 (2022).
    1. Flotte, T.R. & Gessler, D.J. Gene therapy for rare neurological disorders. Clin. Pharmacol. Ther. 111, 743-757 (2022).

Publication types

LinkOut - more resources